BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vieira-rocha M, Rodríguez-rodríguez P, Sousa J, González M, Arribas S, López de Pablo A, Diniz C. Vascular angiotensin AT1 receptor neuromodulation in fetal programming of hypertension. Vascular Pharmacology 2019;117:27-34. [DOI: 10.1016/j.vph.2018.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Vieira-Rocha MS, Sousa JB, Rodriguez-Rodriguez P, Morato M, Arribas SM, Diniz C. Insights into sympathetic nervous system and GPCR interplay in fetal programming of hypertension: a bridge for new pharmacological strategies. Drug Discov Today 2020;25:739-47. [PMID: 32032706 DOI: 10.1016/j.drudis.2020.01.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Dalmasso C, Chade AR, Mendez M, Giani JF, Bix GJ, Chen KC, Loria AS. Intrarenal Renin Angiotensin System Imbalance During Postnatal Life Is Associated With Increased Microvascular Density in the Mature Kidney. Front Physiol 2020;11:1046. [PMID: 32982785 DOI: 10.3389/fphys.2020.01046] [Reference Citation Analysis]
3 Morales-Rubio RA, Alvarado-Cruz I, Manzano-León N, Andrade-Oliva MD, Uribe-Ramirez M, Quintanilla-Vega B, Osornio-Vargas Á, De Vizcaya-Ruiz A. In utero exposure to ultrafine particles promotes placental stress-induced programming of renin-angiotensin system-related elements in the offspring results in altered blood pressure in adult mice. Part Fibre Toxicol 2019;16:7. [PMID: 30691489 DOI: 10.1186/s12989-019-0289-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
4 Junho CVC, Trentin-Sonoda M, Panico K, Dos Santos RSN, Abrahão MV, Vernier ICS, Fürstenau CR, Carneiro-Ramos MS. Cardiorenal syndrome: long road between kidney and heart. Heart Fail Rev 2022. [PMID: 35133552 DOI: 10.1007/s10741-022-10218-w] [Reference Citation Analysis]
5 Facchi JC, Lima TAL, Oliveira LR, Costermani HO, Miranda GDS, de Oliveira JC. Perinatal programming of metabolic diseases: The role of glucocorticoids. Metabolism 2020;104:154047. [PMID: 31837301 DOI: 10.1016/j.metabol.2019.154047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Costa TJ, De Oliveira JC, Giachini FR, Lima VV, Tostes RC, Bomfim GF. Programming of Vascular Dysfunction by Maternal Stress: Immune System Implications. Front Physiol 2022;13:787617. [DOI: 10.3389/fphys.2022.787617] [Reference Citation Analysis]
7 Masi S, Uliana M, Virdis A. Angiotensin II and vascular damage in hypertension: Role of oxidative stress and sympathetic activation. Vascul Pharmacol 2019;115:13-7. [PMID: 30707954 DOI: 10.1016/j.vph.2019.01.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
8 Bourque SL, Davidge ST. Developmental programming of cardiovascular function: a translational perspective. Clin Sci (Lond) 2020;134:3023-46. [PMID: 33231619 DOI: 10.1042/CS20191210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Gutiérrez-Arzapalo PY, Rodríguez-Rodríguez P, Ramiro-Cortijo D, Gil-Ortega M, Somoza B, de Pablo ÁLL, González MDC, Arribas SM. Fetal Undernutrition Induces Resistance Artery Remodeling and Stiffness in Male and Female Rats Independent of Hypertension. Biomedicines 2020;8:E424. [PMID: 33081182 DOI: 10.3390/biomedicines8100424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]